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rates for HF (34%) is consistent with that generally reported in NYHA Class 11-111 systolic 
dvsfunction heart failure. 
1136-81 Evolution of Left Ventricular Filling Pattern Among 
American Indians: The Strong Heart Study 
Felizen S. Aano, Jennifer E. Liu, Marcello Chin&, Dawn Fishman, Jonathan N. Bella, 
James Galloway, Elisa T. Lee, Lyle Best, Richard B. Devereux, Weill Medical College of 
Cornell University, New York, NY 
Background: Relations of left ventricular (LV) diastolic filling patterns to hypertension and 
overweight have been extensively examined in cross-sectional studies but there are few 
data on long-term evolution of LV filling parameters in population-based samples. 
Methods: LV filling parameters were measured by Doppler echocardiography 7.2kO.7 
years apart in 247 American Indian participants (69% women, 58~7 years of age at base- 
line evaluation) in the population-based Strong Heart Study. 
Results: Between examtnations, there were no significant changes rn the systolic blood 
pressure (from 135+16 to 137*19mmHg, NS) and body mass index (both=32*6 kg/m’, 
NS). LV mass increased from 153e.36 to 168*36 g with decreases in LV fractional shorl- 
ening (35+5 to 33+ 6%, both p<OOOi) and LV midwall shortening (17.6Q.3 to 
17.1&3%, p=O.OOl). In parallel, there were decreases ln the peak E wave velocity 
(59-tl6 to 50+13 cm/?@ peak A wave velocity (71+16 to 66+14 cm/set) and the E/A 
ratio of transmttral flow (0.87+0.27 to 0.76r0.21, all pcO.001) accompanied by an 
increased prevalence of E/A ratio below a prognostically-validated partition value of 0.60 
(14 6% to 17.4%, p<O.O2). The decline between examinations in the mitral E/A ratio was 
related to older age at baseline evaluation (r=0.19, p=O.O02) and lesser decrease in ejec- 
bon fraction (r=-0.18, p=O.O07) but not to gender or change in body mass Index or sys- 
tollc pressure. In multiple regression analysis, the decline in mitral E/A ratio was greater 
with higher initial age (p=O.Ol) and less with decline in LV ejection fraction (p=O.O26) but 
was unrelated to temporal change in arterial pressure, LV mass, or body mass index. 
Conclusions: In a population-based sample of mtddle-aged and elderly adults, a 7-year 
follow-up of LV filling pattern among 247 American Indians participants showed that 
there was significant increase in the prevalence of transmitral E/A ratio below a prognos- 
tically-validated partition value. The decline between examinations in the mitral E/A ratio 
was related to older age at baseline evaluation and less with decline in ejection fraction 
and was unrelated to temporal change in arterial pressure, gender difference, LV mass, 
or body mass index 
1136-82 Evidence of Impaired Left Atrial Function Response to 
Exercise in Hypertrophic Cardiomyopathy Patients With 
Heart Failure 
Cinzia Cianfrocca, Francesco Pelliccia. Antonio Auriti, Furio Colivicchi, Antonino 
Granatelli, Giuseppe Richichi. Massimo Santlni. San Filippo Neri Hospital, Rome, Italy 
Background: Studies on determinants of symptoms of heart failure (HF) in pts with 
hypertrophic cardiomyopathy (HC) have focused mainly on LV systolic and/or diastolic 
dysfunction, whereas the pathophysiologic role of left atnal (LA) dynamics has been 
poorly investigated. To address this issue, we investigated the LA systolic function at rest 
and on exercise in a subset of HC pts with mild HF. 
Methods: Fifteen HC pts in NYHA class II (Gr.A; age: 47211 yrs) and 15 sax- and age- 
matched HC pts without symptoms of HF (Gr.6; age: 49_+12 yrs) were studied. All pts 
underwent, off-drug, a symptom-limited supine bicycle exercise test (25 watt/P mins). 
Doppler echocardiography was performed at baseline and at peak exercise. Indexes of 
LA morphology and function were derived from the apical 4. and P-chamber wws. 
Results: At baseline, the 2 groups exhibited similar LV morphology (i.e. maximal wall 
thickness and diameters), LV ejection fraction (55111 vs 63+9%, NS), and Doppler mea- 
sures of LV diastolic performance, i.e. E-peak (45217 vs 49119 cm/s, NS) and A-peak 
(66216 vs 61215 cm/s, NS). Also, they had similar LA maximal volume (7317 vs 71221 
cm3). LA stroke volume (11+8 vs 12+8 cd), and LA emptying fra& (l&9 vs 
25+10%). Exercise time was 441+220 s in Gr.A and 56e297 s in Gr.B. On exercise, LV 
ejection fraction did not change in Gr.A (-al 0%) but increased in Gr.B (+I &lo%, 
p<O.O5). No significant change with exercise in LA stroke volume (++6 ems) and LA 
emptying fraction (+&6) were seen in Gr.A. On the opposite, Gr.B showed an increase 
with exercise in LA stroke volume (+&8 ems, p&01), and LA emptying fraction 
(+15+10%, p<O.Ol). Comparison of Doppler indexes of LV filling in Gr.A showed no 
change with exercise in E-peak (-7~10 cm/s) and A-peak (+a10 cm/s). In Gr.B, con- 
versely, there were on exercise a slight increase in E-peak (+I9215 cm/s) and a signifi- 
cant augmentation in A-peak (+35+19 cm/s, p<O.Ol). 
Conclusion: Along with LV dynazc abnormalities, an impalred LA function response to 
exercise plays a pathophysiologic role in determining symptoms of mild HF in HC. These 
findings provide evidence that the LA myocardium is involved by the myopathic process 
in a subset of pts with HC. 
1136-83 100 Patients Supported for Over One Year on an 
Implanted Left Ventricular Assist Device 
R. Hetzer. R. Koerfer, M. Vigano, M. Pasque, R. Kormos, P. Partner, Tofv Mussivand on 
behalf of the Novacor LVAS Investigators, University of Ottawa Heart Institute. Ottawa, 
ON, Canada 
Background: The use of mechanical circulatory support (MCS) devices during the 
bridge to transplant experience can provide clinical insight into the potential use of these 
devices for long-term support or “Destination Therapy”. A review of the outcomes of first 
100 end-stage heart failure patients supported for greater than 1 year with an implanted 
left ventricular assist device (Novacor LVAS) was conducted. Methods: Utilizing data 
from the international registry, the patient characteristics and outcomes of 100 patients 
supported for > 1 year at 40 international centres were analyzed. Results: The patients 
ware 90% male with a mean age of 47 years (16-72 years). The disease etiology was 
cardiomyopathy in 63%, ischemic heart disease in 26% and other in 10%. The Intent to 
treat was as follows: 92% as a bridge to transplant. 4% as a bridge to recovery (Europe) 
and 4% as an alternative to transplant. Mean support duration on the device was 1.7 
years (370-1514 days) and 22 patients were supported over 2 years, 8 ovar 3 years and 
3 over 4 years. Outcomes were favorable (either ongoing, transplanted or weaned) for 
78% of patients. Subsequent analysis of patients supported over 6 months and I, 2, & 3 
years respectively, yielded similar outcomes at each time interval. There were no deaths 
related to device failure and the majority of patients were able to return home to near nor- 
mal activities.Conclusions: 1) A significant majority (78%) of these end-stage heart fail- 
ure patients had favorable outcomes and extension of life. 2) Improved quality of life was 
demonstrated with the majority of patients discharged from hospital. 3) Overall device 
safety has been demonstrated with no patient deaths due to device failure, and 4) Long- 
tern dewce durability has been demonstrated with patients supported for over 4 years on 
a single devce. These findings provide clear evidence that mechanical circulatory sup- 
port could potentially provide substantial clinical benefits during long-term support or 
“Destination Therapy”. 
* Due to space limitations only investigators with more than 5 patients supported over 1 
year are listed. 
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1137-62 Expanding the Donor Pool: Acceptable Recipient 
Outcomes With the Use of Hearts From Donors With 
Hepatitis B Core Antibody Positivity or Intracranial 
Tumors 
Sean P. Pinney Faisal H. Cheema, Kim Marie Hammond, Jonathan Chen, Niloo M. 
Edwards, Donna Mancini, Columbia University, New York, NY 
Background: The shortage of avallable donors limits cardiac transplantation. Transplan- 
tation of hearts from marginal donors could expand the donor pool if accompanied by 
good recipient outcomes. Donor hearts from patients with hepatitis B core antibodies 
(HBcAb) have not been used due to concern about virus transmission. Similarly, donors 
with malignant brain tumors have also been excluded. We conducted a retrospective 
review to determine the success of transplanting hearts from donors who were HBcAb+ 
or had an Intracranial tumor. Methods: We reviewed donor and recipient charts for 
patients transplanted at our center between January 1. 1997 and September I, 2002. 
Results: Of 514 hearl transplants performed in this time period, 46 (8.9%) used hearts 
from these marginal donors Fourteen patients (age 56+11 years) received hearts from 
donors with an intracranial tumor (age 4Ot9.6 years) Including 6 glioblastoma multiforme, 
2 anaplastic astrocytoma, 1 astrocytoma, 1 medulloblastoma. 1 pineal tumor. 1 meningi- 
oma and 2 not specified. At 23*10 months of follow-up, no patient had clinical or radio- 
logic evidence of tumor transmission. Thirty-two patients (age 46.9+18.7 years) received 
heatis from HBcAb+ donors (age 37.5*11 .O years). One patient (baseline HBSAg-) 
developed donor-transmitted HBV infection 10 months post-transplant that was success- 
fully treated with lamivudine. Two patients (baseline HBSAb-) had HBV seroconversion 
(HBSAb+) without evidence of HBV infection. Six patients were HBSAb+ pre-transplant 
and four patients (HBSAb-) received prophylactic lamivudine post-transplant. None of 
these patients developed donor-transmitted hepatitis; one lamivudine-treated patient 
